Evidence map›Paper›PMID 19028547›Full record

ReviewMolecular and cellular endocrinology2009

Structure and function of the melanocortin2 receptor accessory protein (MRAP).

Patricia M Hinkle, Julien A Sebag

Open access · greenAbstract readReview
In one paragraph

Review in Molecular and cellular endocrinology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 97 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Arginine 125 Is an Essential Residue for the Function of MRAP2.International journal of molecular sciences · 2022
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Patricia M HinkleDepartment of Pharmacology and Physiology, University of Rochester Medical Center, Rochester, NY 14642, United States. patricia_hinkle@urmc.rochester.edu
Julien A Sebag
University of Rochester Medical Center · US

Funding

MODULATION OF RECEPTOR NUMBER IN CULTURED CELLSR01DK019974 · NIDDK · UNIVERSITY OF ROCHESTER · PI HINKLE, PATRICIA M. · 1986 to 2011
$4.1M
NIDDK NIH HHS DK19974NIDDK NIH HHS R01 DK019974
6 · The paper itself

Abstract

The melanocortin2 (MC2), or ACTH receptor, requires MC2 receptor accessory protein (MRAP) for function, and individuals lacking MRAP are ACTH-resistant and glucocorticoid-deficient. MRAP facilitates trafficking of the MC2 receptor to the plasma membrane and is absolutely required for ACTH binding and stimulation of cAMP. MRAP, which contains a single transmembrane domain, has a unique structure, an antiparallel homodimer. It can be isolated from the plasma membrane in a complex with the MC2 receptor. A short sequence just aminoterminal to the transmembrane domain of MRAP is essential for dual topology, while the transmembrane region is not; both are necessary for function. Deletion or alanine-substitution of other aminoterminal regions yields MRAP mutants that promote surface expression of the MC2 receptor but not receptor signaling. These results identify two distinct actions of MRAP: to permit trafficking of the MC2 receptor, and to allow surface receptor binding and signaling.

Indexed as

Protein Structure, QuaternaryAdrenocorticotropic HormoneAnimalsCell LineHumansMembrane ProteinsAdrenocorticotropic HormoneMembrane ProteinsMRAP protein, human

Identifiers

PMID19028547
PMCPMC2677758
OpenAlexW2070907801

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.